Literature DB >> 9834959

Solubility properties of racemic praziquantel and its enantiomers.

S K el-Arini1, D Giron, H Leuenberger.   

Abstract

The purpose of this study was to characterize the solubility and thermodynamic properties of the optical isomers of the anti-schistosomal drug, praziquantel (PZQ) and to compare these properties to those of the racemic product used in commercial preparations (Biltricide, generic drugs). The crystalline enantiomers of PZQ exhibited different thermal properties than the racemic drug. The melting points and the enthalpies of fusion obtained from the differential scanning calorimetry (DSC) scans were nearly identical between the isomers and were substantially lower than those of racemic PZQ [(+/-)-PZQ]. The DSC results indicate that (+/-)-PZQ is a racemic compound and not a racemic mixture. This was confirmed by powder x-ray diffraction analysis and the IR spectra. The 30 degrees decrease in the melting point was reflected in increased solubility of the enantiomers, which amounted to twice that of the racemic PZQ. The behavior of the isomers in the presence of beta-cyclodextrin (beta-CD) was studied in water at 37 degrees C. The solubility data (phase solubility diagrams) were linear for up to the highest concentration of added beta-CD investigated. The apparent stability constants determined from the phase solubility diagrams showed that both the (+) and (-) enantiomers as well as (+/-)-PZQ exhibited moderate affinity to form a 1:1 complex in solution with beta-CD. The findings of this study may be of importance when efforts are considered to improve pharmaceutical formulation of this anti-schistosomal drug.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834959     DOI: 10.3109/10837459809028638

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  5 in total

1.  Molecular modeling and infrared and Raman spectroscopy of the crystal structure of the chiral antiparasitic drug Praziquantel.

Authors:  Ana Borrego-Sánchez; Alfonso Hernández-Laguna; C Ignacio Sainz-Díaz
Journal:  J Mol Model       Date:  2017-03-08       Impact factor: 1.810

2.  Effects of Formulation on the Palatability and Efficacy of In-Feed Praziquantel Medications for Marine Finfish Aquaculture.

Authors:  Edith K Y Tang; Gavin J Partridge; Lindsey D Woolley; Luke Pilmer; Lee Yong Lim
Journal:  Mar Drugs       Date:  2022-05-13       Impact factor: 6.085

3.  Effect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.

Authors:  Stratos Maragos; Helen Archontaki; Panos Macheras; Georgia Valsami
Journal:  AAPS PharmSciTech       Date:  2009-12-01       Impact factor: 3.246

4.  Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control.

Authors:  Bin Jiang; Xiao-Nong Zhou; Hao-Bing Zhang; Yi Tao; Le-Le Huo; Ni Liu
Journal:  Infect Dis Poverty       Date:  2017-09-15       Impact factor: 4.520

5.  Chiral Recognition R- and RS- of New Antifungal: Complexation/Solubilization/Dissolution Thermodynamics and Permeability Assay.

Authors:  Tatyana V Volkova; Olga R Simonova; Igor B Levshin; German L Perlovich
Journal:  Pharmaceutics       Date:  2022-04-15       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.